Reumatología
Servicio
University Hospital of Zurich
Zúrich, SuizaPublicaciones en colaboración con investigadores/as de University Hospital of Zurich (18)
2023
-
2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases
Annals of the Rheumatic Diseases, Vol. 82, Núm. 1, pp. 48-56
-
Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review
Seminars in Arthritis and Rheumatism, Vol. 58
-
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment
Journal of Rheumatology, Vol. 50, Núm. 8, pp. 1009-1019
2022
-
Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): Systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
RMD Open, Vol. 8, Núm. 2
-
Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
RMD open, Vol. 8, Núm. 1
-
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response
Rheumatology (Oxford, England), Vol. 61, Núm. 9, pp. 3799-3807
-
Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
RMD open, Vol. 8, Núm. 1
-
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis
Rheumatology (Oxford, England), Vol. 61, Núm. 12, pp. 4741-4751
2021
-
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration
Annals of the Rheumatic Diseases, Vol. 80, Núm. 11, pp. 1410-1418
2020
-
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration
RMD open, Vol. 6, Núm. 3
-
EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries
Annals of the Rheumatic Diseases, Vol. 79, Núm. 11, pp. 1423-1431
-
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis
Rheumatology (United Kingdom), Vol. 59, Núm. 9, pp. 2455-2461
2019
-
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database
Scandinavian Journal of Rheumatology, Vol. 48, Núm. 1, pp. 42-51
-
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
Annals of the Rheumatic Diseases, Vol. 78, Núm. 11, pp. 1536-1544
2018
-
Gender differences in early systemic sclerosis patients: A report from the EULAR scleroderma trials and research group (EUSTAR) database
Clinical and Experimental Rheumatology, Vol. 36, pp. S68-S75
2017
-
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 35, pp. S114-S121
2015
2011
-
Treating rheumatoid arthritis to target: Multinational recommendations assessment questionnaire
Annals of the Rheumatic Diseases, Vol. 70, Núm. 11, pp. 1999-2002